Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

CUSIP: 03753U106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
125,684,656
Total 13F shares
113,630,426
Share change
+7,330,240
Total reported value
$4,326,001,749
Put/Call ratio
37%
Price per share
$38.04
Number of holders
250
Value change
-$249,890,323
Number of buys
163
Number of sells
167

Quarterly Holders Quick Answers

What is CUSIP 03753U106?
CUSIP 03753U106 identifies APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q3 2023

As of 30 Sep 2023, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by 250 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 113,630,426 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock Inc., JENNISON ASSOCIATES LLC, STATE STREET CORP, Octagon Capital Advisors LP, and FMR LLC. This page lists 251 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.